Maze Therapeutics, Inc. ($MAZE)
Filing Information
| Accession Number | 0002050172-26-000034 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 4, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
10,295
Total Value
$270,110.79
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D&CMO | Common Stock | โ | Sep 2, 2026 | Sale | 4,481 | $26.38 | $118,190.86 | 15,519 | Direct | โ | View Details | |
President, R&D&CMO | Common Stock | โ | Sep 2, 2026 | Sale | 625 | $27.12 | $16,950.69 | 14,894 | Direct | โ | View Details | |
President, R&D&CMO | Common Stock | โ | Sep 3, 2026 | Sale | 5,130 | $26.01 | $133,448.23 | 9,764 | Direct | โ | View Details | |
President, R&D&CMO | Common Stock | โ | Sep 3, 2026 | Sale | 59 | $25.78 | $1,521.02 | 9,705 | Direct | โ | View Details |